Avalo Therapeutics AVTX
NASDAQ AVTX
$8.51 +1.35 (+18.85%)
At close: Nov 11, 2026 · 4:00 PM EST

Avalo Therapeutics (AVTX) Long-Term Debt Issuances (2014 - 2021)

Updated

Avalo Therapeutics' Long-Term Debt Issuances was $7.39 million in FY2014.

Analysis

Avalo Therapeutics (AVTX) Long-Term Debt Issuances (2014 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Avalo Therapeutics 386.09 Mn -587.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 13.29 Mn
Dec 31, 2014 -2.25 Mn
API Access

Avalo Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=AVTX&period=max&api_key=YOUR_API_KEY